Phenylketonuria is a human genetic disorder commonly known as classical PKU, which is a birth defect that is caused by an inborn in error amino acid metabolism. The condition is autosomal recessive and is characterized by the absence of the hepatic enzyme phenyl-alanine hydroxylase. This enzyme catalyses the hydroxylation of phenylalanine to tyrosine and the lack of activity causes severe mental retardation in untreated children. The prevalance of this hereditary disorder among caucaseans ranges from 1/5,400 in Ireland to 1/1,600 in Switzerland, with an average of about 1/8,000 in the United States. It has been estimated that 2 percent of the population are heterozygous carriers of this genetic disorder. Neonatal screening of all new-born infants for PKU is mandated by law in many Western countries including the United States since the disorder can be treated with limited success by long-term dietary correction. There is however no available means for prevention of the disorder due to the lack of reliable analytical methodologies for identification of heterozygous adults and homozygous recessive fetuses. Since amino acid sequence of the enzyme has not been determined, whether there are amino acid substitutions between the normal and PKU proteins are not known at the present time. Using Recombinant DNA Technology, we propose to isolate and characterize the human phenylalanine hydroxylase gene from normal and deficient individuals by molecular cloning. Comparison of the structural organization and nucleotide sequence between the cloned genes should reveal any amino acid substitutions in the variant proteins and would thereby establish the molecular basis of the deficiency at the gene level. This information will then permit the development of a simple and reliable method for heterozygote identification and prenatal diagnosis of the genetic disorder by gene mapping. Early detection of individuals with the genetic trait and prenatal diagnosis will promote prevention of the deficiency through genetic counceling. Finally, attempts will be made to better understand the cause(s) of the deficiency by examining the expression of the deficient genes after their introduction through DNA-mediated gene transfer into human cells in culture.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD017711-05
Application #
3314733
Study Section
Biochemistry Study Section (BIO)
Project Start
1983-04-01
Project End
1988-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Enns, G M; Martinez, D R; Kuzmin, A I et al. (1999) Molecular correlations in phenylketonuria: mutation patterns and corresponding biochemical and clinical phenotypes in a heterogeneous California population. Pediatr Res 46:594-602
Santos, M; Kuzmin, A I; Eisensmith, R C et al. (1996) Phenylketonuria in Costa Rica: preliminary spectrum of PAH mutations and their associations with highly polymorphic haplotypes. Hum Hered 46:128-31
Eisensmith, R C; Woo, S L (1995) Molecular genetics of phenylketonuria: from molecular anthropology to gene therapy. Adv Genet 32:199-271
Eisensmith, R C; Goltsov, A A; Woo, S L (1994) A simple, rapid, and highly informative PCR-based procedure for prenatal diagnosis and carrier screening of phenylketonuria. Prenat Diagn 14:1113-8
Li, J; Eisensmith, R C; Wang, T et al. (1994) Phenylketonuria in China: identification and characterization of three novel nucleotide substitutions in the human phenylalanine hydroxylase gene. Hum Mutat 3:312-4
Wang, Y; Hahn, T M; Tsai, S Y et al. (1994) Functional characterization of a unique liver gene promoter. J Biol Chem 269:9137-46
Svensson, E; von Dobeln, U; Eisensmith, R C et al. (1993) Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr 152:132-9
Goltsov, A A; Eisensmith, R C; Naughton, E R et al. (1993) A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet 2:577-81
Svensson, E; Wang, Y; Eisensmith, R C et al. (1993) Three polymorphisms but no disease-causing mutations in the proximal part of the promoter of the phenylalanine hydroxylase gene. Eur J Hum Genet 1:306-13
Eisensmith, R C; Woo, S L (1992) Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat 1:13-23

Showing the most recent 10 out of 70 publications